OBJECTIVE: To determine if health-related quality of life (HRQL) in patients of middle age and older with elevated thyroid-stimulating hormone (TSH) and normal total thyroid hormone levels—subclinical hypothyroidism—improves withl-thyroxine replacement therapy.
PATIENTS: Thirty-seven patients with subclinical hypothyroidism, most with symptoms consistent with hypothyroidism, over 55 years of age.
INTERVEJVTIOJVS: Placebo or L-thyroxine replacement therapy to achieve normal TSH level.
MEASUREMENTS AND MAIN RESULTS: Disease-specific and general HRQL, cognitive function, bone mineral density, lipid levels. The mean daily dose of L-thyroxine replacement in the active group was 68±21 µg. TSH decreased by 8.6 mIU/L (95% confidence interval [CI] 4.1 to 13.1) and T4 increased by 27.9 nmol/L (95% CI 14.8 to 41.2). There was a statistically significant improvement in a composite psychometric memory score in treated versus control patients; all other outcomes showed similar findings in the two groups. Although confidence intervals for most measures did not exclude an important improvement in HRQL with thyroid replacement, no measure of symptoms or HRQL either showed clinically important trends in favor of treatment, or approached conventional levels of statistical significance.
CONCLUSIONS: In middle-aged and older patients with elevated TSH and normal T4, it may not be harmful to follow biochemical and clinical status even in the presence of nonspecific symptoms potentially associated with hypothyroidism.
Subclinical hypothyroidism quality of life elderly
This is a preview of subscription content, log in to check access.
Turnbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Wickhan survey. Clin Endocrinol (Oxf). 1977;7:481–93.Google Scholar
Rosenthal MJ, Hunt WC, Garry PJ, et al. Thyroid function in the elderly: microsomal antibodies as discriminant for therapy. JAMA. 1987;258:209–13.PubMedCrossRefGoogle Scholar
Pacchiarotti A, Martino E, Bartalena L, et al. Serum free thyroid hormones in subclinical hypothyroidism. J Endocrinol Invest. 1986;9:315–9.PubMedGoogle Scholar
Ferrara C, Paracchi E, Parisio E, et al. Serum free thyroid hormones in different degrees of hypothyroidism and in euthyroid autoimmune thyroiditis. Acta Endocrinol (Copenh). 1987;114:559–64.Google Scholar
Bell GM, Todd WTA, Forfar JC, et al. End-organ responses to thyroxine in subclinical hypothyroidism. Clin Endocrinol (Oxf). 1985;22:83–9.Google Scholar
Forfar JC, Wathem CG, Todd WT, et al. Left ventricular performance in subclinical hypothyroidism. QJM. 1985;57:857–65.PubMedGoogle Scholar
Cooper DS, Halpem R, Wood LC, Levin AA, Ridgway EC. L-Thyroxine therapy in subclinical hypothyroidism. A double blind, placebo controlled trial. Ann Intern Med. 1984;101:18–24.PubMedGoogle Scholar
Ridgway EC, Cooper DS, Walker H, Rodbard D, Haloof F. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 1981;53:1238–42.PubMedCrossRefGoogle Scholar
Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P-A, Lindstedt G. A double-blind cross-over 12-month study ofl-thyroxine treatment of women with “subclinical” hypothyroidism. Clin Endocrinol. 1988;29:63–76.Google Scholar
Campbell AJ. Thyroid disorders in the elderly. Difficulties in diagnosis and treatment. Drugs. 1986;31:455–61.PubMedGoogle Scholar
Bansal SK, Sahi SP, Basu SK. Old JM. Hypothyroidism in elderly males—an under diagnosis. Br J Clin Pract. 1986;40:17–8.PubMedGoogle Scholar
Felicetta JV. Thyroid changes with aging: significance and management. Geriatrics. 1987;42:86–8,91–2.PubMedGoogle Scholar
Ross DS, Neer RM, Ridgway EC, Daniels GH. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med. 1987;82:1167–70.PubMedCrossRefGoogle Scholar
Coindre JM, David JP, Riviere L, et al. Bone loss in hypothyroidism with hormone replacement. A histomorphometric study. Arch Intern Med. 1986;146:48–53.PubMedCrossRefGoogle Scholar
Ross DS. Bone density is not reduced during the short-term administration of levo-thyroxine to postmenopausal women with subclinical hypothyroidism: a randomized, prospective study. Am J Med. 1993;95:38–58.CrossRefGoogle Scholar
Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med. 1987;316:764–70.PubMedCrossRefGoogle Scholar
Jaeschke R, Guyatt G, Cook D, Harper S, Gerstein HC. Spectrum of quality of life impairment in hypothyroidism. Qual Life Res. 1994;3:323–7.PubMedCrossRefGoogle Scholar
Jaeschke R, Stager J, Guyatt G. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407–15.PubMedCrossRefGoogle Scholar
Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life instrument. J Clin Epidemiol. 1994;47:81–7.PubMedCrossRefGoogle Scholar
Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res. 1996;5:35–46.PubMedCrossRefGoogle Scholar
Bergner M, Robbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of health status measure. Med Care. 1981;19:797–805.CrossRefGoogle Scholar
Rockey PH, Griep RJ. Behavioral dysfunction in hyperthyroidism. Improvement with treatment. Arch Intern Med. 1980;140:1194–7.PubMedCrossRefGoogle Scholar
Lezak MD. Neuropsychological Assessment. 2nd ed. New York, NY: Oxford University Press; 1983.Google Scholar
Spreen O, Strauss E. Compendium of Neuropsychological Tests. New York, NY: Oxford University Press; 1991.Google Scholar
Molloy DW, Beerschoken DA, Borrie MJ, Crilly RG, Cape RDT. Acute effects of exercise on neuropsychological function in elderly subjects. J Am Geriatr Soc. 1988;36:29–33.PubMedGoogle Scholar
Denburg SD, Carbotte RM, Denburg JA. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum. 1994;97:1311–20.CrossRefGoogle Scholar
Webber C. Some factors which influence the evaluation of dual photon measurement of lumbar spine bone mineral mass. J Can Assoc Radiol. 1989;40:87–91.Google Scholar
Nottestad SY, Baumel JJ, Kimmel DB, Recker RR, Henney RP. The proportion of trabecular bone in human vertebrae. J Bone Miner Res. 1987;2:221–9.PubMedCrossRefGoogle Scholar